Causal Relationships Between Epilepsy, Anti‐Epileptic Drugs, and Vitamin D
Author Information
Author(s): Cheng Zizhang, Zuo Jinyi, Peng Xintao, Zhang Haoran, Su Wenlong, Luan Guoming, Guan Yuguang
Primary Institution: Capital Medical University
Hypothesis
This study aims to investigate the causal relationships among epilepsy, anti‐epileptic drugs, and levels of vitamin D and vitamin D-binding protein.
Conclusion
No causal relationships were found between genetically determined serum 25(OH)D levels, VDBP, and epilepsy or its subtypes.
Supporting Evidence
- Previous studies suggest potential associations between epilepsy, anti‐epileptic drugs, and vitamin D levels.
- Genetically predicted focal epilepsy risk was potentially associated with increased serum 25(OH)D levels.
- Higher genetic risk of juvenile myoclonic epilepsy was linked to lower VDBP levels.
- Significant associations were observed between serum 25(OH)D levels and AED target genes.
- Anti-epileptic drugs reduce serum 25(OH)D levels without affecting VDBP levels.
Takeaway
The study looked at how epilepsy and certain medications affect vitamin D levels, but found no clear cause-and-effect relationships.
Methodology
The study used Mendelian Randomization methods with summary data from genome-wide association studies.
Potential Biases
Residual confounding may still affect the results.
Limitations
The study's data were not stratified, and the reliability of extrapolating genetic data from newborns to adults is uncertain.
Participant Demographics
Participants included individuals of European descent.
Statistical Information
P-Value
0.017
Confidence Interval
1.006–1.058
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website